TRANSCATHETER ARTERIAL CHEMO-EMBOLIZATION OF RENAL-CELL CARCINOMA WITH MICROENCAPSULATED MITOMYCIN-C
TRANSCATHETER ARTERIAL CHEMO-EMBOLIZATION OF RENAL-CELL CARCINOMA WITH MICROENCAPSULATED MITOMYCIN-C
复制标题
DOI:
10.1016/s0022-5347(17)54880-6
复制
发表时间:
1981-01-01
影响因子:
6.6
通讯作者:
TAMAKAWA, Y
中科院分区:
文献类型:
--
作者:
KATO, T;NEMOTO, R;TAMAKAWA, Y
Ethylcellulose microcapsules of mitomycin C were prepared for intra-arterial use to enhance the antineoplastic effects of mechanical arterial embolization. The potential therapeutic effects of intra-arterial mitomycin C microcapsules were considered a function of microembolization and prolonged drug action, i.e., chemoembolization. A total of 33 patients with renal cell carcinoma was subjected to transcatheter arterial chemoembolization with mitomycin C microcapsules supplemented with gelatin sponge; 10 patients were subjected to chemoembolization with non-encapsulated mitomycin C and gelatin sponge. Comparative studies on objective tumor decrease, angiographical findings and histological effects between the 2 treated groups indicated that mitomycin C microcapsules definitely enhanced the therapeutic responses to gelatin sponge embolization. Bioassay of the peripheral blood revealed that intra-arterial mitomycin C microcapsules reduced markedly mitomycin C levels in the blood compared to non-encapsulated mitomycin C, leading to a decrease in hematological toxicity. Chemoembolization with mitomycin C microcapsules probably is effective as a preoperative and palliative measure in the treatment of renal cell carcinoma.